DR
Dorrilyn Rajbhandari
Also known as: D Rajbhandari
The George Institute for Global Health, Royal Prince Alfred Hospital
Research areas: Medicine · Critical Care and Intensive Care Medicine · Sepsis Diagnosis and Treatment · Adrenal Hormones and Disorders · Hyperglycemia and glycemic control in critically ill and hospitalized patients
0000-0001-8883-0428
Employment
-
The George Institute for Global Health Senior Project Manager2010 - Present
-
Royal Prince Alfred Hospital Research Coordinator1997 - 2012
Education
Education history is unavailable.
Projects & Funding
Projects & funding information is unavailable.
Publications (81)
- Continuous infusion of Beta-Lactams in the critically ill: Considerations for global implementation Save
- Fludrocortisone to treat patients with aneurysmal subarachnoid haemorrhage: Protocol for an international, phase 3, randomised, placebo-controlled, multicentre trial Save
- Hydrocortisone and Risk Factors for Kidney Replacement Therapy in Septic Shock Save
- Buffered salt solution versus 0.9% sodium chloride as fluid therapy for patients presenting with moderate to severe diabetic ketoacidosis: Study protocol for a Phase-3 cluster-crossover, blinded, randomised, controlled trial Save
- Fludrocortisone dose–response relationship in septic shock: a randomised phase II trial Save
- Is it time to implement prolonged infusions of beta‐lactam antibiotics in and beyond critical care settings? Save
- Continuous vs Intermittent β-Lactam Antibiotic Infusions in Critically Ill Patients With Sepsis Save
- Prolonged vs Intermittent Infusions of β-Lactam Antibiotics in Adults With Sepsis or Septic Shock Save
- Stress Ulcer Prophylaxis during Invasive Mechanical Ventilation Save
- Protocol implementation during the COVID-19 pandemic: experiences from a randomized trial of stress ulcer prophylaxis Save
- A Genome-Wide Association Study of Serum Metabolite Profiles in Septic Shock Patients Save
- Hydroxychloroquine plus personal protective equipment versus personal protective equipment alone for the prevention of laboratory-confirmed COVID-19 infections among healthcare workers: a multicentre, parallel-group randomised controlled trial from India. Save
- Challenges in operationalising clinical trials in India during the COVID-19 pandemic. Save
- Effect of 12 mg vs 6 mg of Dexamethasone on the Number of Days Alive Without Life Support in Adults With COVID-19 and Severe Hypoxemia: The COVID STEROID 2 Randomized Trial. Save
- Hydroxychloroquine Plus Standard Personal Protective Equipment Versus Standard Personal Protective Equipment Alone for the Prevention of Laboratory Confirmed Covid-19 Infections Among Healthcare Workers: A Multi-Centre Parallel Group Randomized Controlle… Save
- The relationship between adrenocortical candidate gene expression and clinical response to hydrocortisone in patients with septic shock Save
- An evaluation of factors that may influence clinicians' decisions not to enroll eligible patients into randomized trials in critical care. Save
- Long-term costs and cost-effectiveness of adjunctive corticosteroids for patients with septic shock in New Zealand. Save
- Sex differences in response to adjunctive corticosteroid treatment for patients with septic shock. Save
- Does asymmetry in patient recruitment in large critical care trials follow the Pareto principle? Save